✦ LIBER ✦
2035 POSTER NEAT-A: Accelerated sequential epirubicin followed by higher dose 14 day CMF, using pegfilgrastim, is a feasible alternative for delivering dose dense E-CMF chemotherapy in early breast cancer
✍ Scribed by S. Bowden; L. Gross; C.J. Poole; L. Hiller; R.K. Agrawal; K.F. McAdam; H.M. Earl; S. Anwar; D. Rea
- Book ID
- 118625639
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 81 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.